Actionable news
0
All posts from Actionable news
Actionable news in ILMN: Illumina, Inc.,

Illumina Files Patent Infringement Suit in Switzerland against Genoma SA for Infringement of NIPT Patents

SAN DIEGO, Apr 21, 2016 (BUSINESS WIRE) -- Illumina, Inc. ILMN, +3.92% today announced that it, and its wholly owned subsidiary, Verinata Health, Inc. (together “Illumina”), filed a patent infringement suit against Genoma SA in the Federal Patent Court in Switzerland. Illumina is seeking all available remedies, including damages and injunctive relief.

The patents asserted are European Patent (CH) 2 183 693 B1, European Patent (CH) 0 994 963 B2, European Patent (CH) 1 981 995 B1, and European Patent (CH) 2 514 842. The patents are directed to using cell-free fetal DNA for non-invasive prenatal testing (NIPT).

The suit accuses Genoma’s...


More